Stock BCDA BIOCARDIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BioCardia, Inc.

Equities

BCDA

US09060U5074

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.3766 USD +2.34% Intraday chart for BioCardia, Inc. +4.61% -43.30%
Apr. 25 BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort CI
Mar. 27 Transcript : BioCardia, Inc., 2023 Earnings Call, Mar 27, 2024

Evolution of the average Target Price on BioCardia, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a5f865db9f321b317.EGUxwJRj1TNN7d4WalRW2H5fGZ1mwIKshUfq-nd-8F0.Uh9lhuEXj1wH2e5VBicu4DtvS6pLjsbIxAHbpRI4hzxTERywojzsZiaUmw~63efe80ca41cd204d3039c94920edc43

Analyst Recommendations on BioCardia, Inc.

HC Wainwright Adjusts BioCardia's Price Target to $4 From $9, Keeps Buy Rating MT
Dawson James Downgrades BioCardia to Neutral From Buy MT
HC Wainwright Starts BioCardia at Buy With $9 Price Target MT
BIOCARDIA : Dawson James Downgrades BioCardia to Neutral from Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.3766 USD
Average target price
4 USD
Spread / Average Target
+962.13%
High Price Target
4 USD
Spread / Highest target
+962.13%
Low Price Target
4 USD
Spread / Lowest Target
+962.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering BioCardia, Inc.

HC Wainwright
Dawson James

Ratings for BioCardia, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BCDA Stock
  4. Consensus BioCardia, Inc.